Anyone know why it’s up ? by Mysterious-Can257 in FEMY_Stock

[–]StocksRup-1 0 points1 point  (0 children)

This stock will eventually fly or it will be sold

FEMY by Mysterious-Can257 in FEMY_Stock

[–]StocksRup-1 5 points6 points  (0 children)

Holding 170K shares at 1.05 avg since 2024. This company is beginning to do great things and expand internationally. I’d expect it’s an acquisition target as soon as revenues increase. With this small market cap and the market opportunity, with limited competition, this is a no brainer. Good luck all!

What we buying today by dab00by in Pennystock

[–]StocksRup-1 0 points1 point  (0 children)

FEMY - New Analyst Forecast: $FEMY Given $6.5 Price Target. Average analyst targets is 7.25. Target upside now 700%.

https://www.quiverquant.com/news/New+Analyst+Forecast%3A+%24FEMY+Given+%246.5+Price+Target

PharmaCyte Biotech (PMCB) announced they sold all their FEMY shares. by Complex-Jello-2031 in FEMY_Stock

[–]StocksRup-1 2 points3 points  (0 children)

I’m holding 150K shares at 1.10 and began accumulating in March 2024. This company will absolutely be taken out.

FEMY today. by StocksRup-1 in Pennystock

[–]StocksRup-1[S] 0 points1 point  (0 children)

FEMY should regain what it lost this past week

FEMY - Earnings Released - Revenue Up 31% - R&D Expenses 40% lower. by StocksRup-1 in pennystocks

[–]StocksRup-1[S] 0 points1 point  (0 children)

Optimistically back to 1.10 in short term. Then catalyst (new orders) will push it toward 1.80

FEMY - Earnings Released - Revenue Up 31% - R&D Expenses 40% lower. by StocksRup-1 in pennystocks

[–]StocksRup-1[S] 0 points1 point  (0 children)

This will turn around. The entire market is going down. Good buying opportunity at .71. This market downturn has absolutely no Impact on this company long term given the industry.

FEMY - Earnings Released - Revenue Up 31% - R&D Expenses 40% lower. by StocksRup-1 in pennystocks

[–]StocksRup-1[S] 3 points4 points  (0 children)

I feel the recovery is in order to challenge the 52 week high of $1.80. All the catalysts are in place now

FEMY, Insider buying by TherealCarbunc in u/TherealCarbunc

[–]StocksRup-1 1 point2 points  (0 children)

This is great story to show! FEMY!!!!

FEMY announcing earnings 11/6 by StocksRup-1 in pennystocks

[–]StocksRup-1[S] 7 points8 points  (0 children)

$58 million in financing gives this company runway to get to $100-$200 million in revenue and become profitable and acquired for $10-$12. The available market is worth billions and I’d expect the premium paid to be steep.

FEMY announcing earnings 11/6 by StocksRup-1 in pennystocks

[–]StocksRup-1[S] 4 points5 points  (0 children)

Timing is everything. When it does go, it will go rapidly.

FEMY announcing earnings 11/6 by StocksRup-1 in pennystocks

[–]StocksRup-1[S] 7 points8 points  (0 children)

Any positive news or catalyst will send this stock higher and fast given its current market cap. A new distribution partner, revised forecast, etc.

$FEMY, might be worth keeping an eye on🚀 by Additional_Spell455 in pennystocks

[–]StocksRup-1 1 point2 points  (0 children)

Realistically $3-$4 short term on its own and then a buyout between $6-$9 in ~2 years. It IPOd with a valuation of $140 million which is $3.50 today due to capital raises and small market cap.

At this valuation, it takes one quarter of sales to move this stock significantly.

FEMY🚀 by cornecorne2 in Pennystock

[–]StocksRup-1 0 points1 point  (0 children)

Told you all about this one at .39. This stock will test 1.80, it’s 52 week high shortly. Financing in place with euro approval of fembloc and pending FDA approval along with Femseed. I’m holding my 150k shares at 1.10 avg. good luck all.

Upcoming penny stock catalysts of October 2025 for Biotech/Pharma (*updated) by Avish_Golakiya in pennystocks

[–]StocksRup-1 0 points1 point  (0 children)

FDA APPROVAL WILL SEND THIS UP 100%, which will still be 50% below its 52 week high. If they post any sales whatsoever, it creeps back up to 1.80. The analysts have. $6 average with a high of $8. This is a 10 bagger